0.0460USDMkt Cap: 174108 USDP/E: —Last update: 2026-05-21
IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The com…
Industry Peers
Medical Care Facilities89.61BTRYP/E 15.8
87.42BUSDP/E 13.6
31.71BSEKP/E 36.8
21.84BEURP/E 14.5
16.19BSEKP/E 19.2
11.90BSEKP/E 17.4
10.01BEURP/E 11.4
9.55BUSDP/E 6.6
loading…
Indicators:|
Key Statistics
Company
Market Cap174.11K USD
Enterprise Value3.96M USD
Revenue (TTM)22.72K USD
Gross Profit-233.20K USD
Net Income (TTM)-9.05M USD
Revenue/Share0.0070 USD
Last Price0.0460 USD
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees15
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA-0.52
EV/Revenue174.17
P/S7.66
P/B-0.01
EPS (TTM)-2.98
EPS (Forward)-3.48
52W Range
—
52W High0.0460 USD
52W Low0.0460 USD
Profitability
Gross Margin-323.66%
Oper. Margin-8733.44%
EBITDA Margin0.00%
Profit Margin-12554.93%
ROE160.43%
ROA-569.27%
Growth
Revenue Growth-62.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.16M USD
CapEx (TTM)—
FCF Margin-2670.48%
FCF Yield-348.53%
Net Debt3.78M USD
Net Debt/EBITDA-0.50
Balance Sheet
Debt/Equity—
Current Ratio0.02
Quick Ratio0.00
Book Value/Sh-3.4290 USD
Cash/Share0.0120 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateSep 8, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.78M
Float3.72M
Insiders1.52%
Institutions0.00%
Short Interest
Short Ratio0.3d
Short % Float2.01%
Short % Out.1.99%
Shares Short66.89K
Short (prev mo.)216.77K
Technical
SMA 500.0530 (-13.2%)
SMA 2000.0773 (-40.5%)
Beta1.70
S&P 52W Chg28.31%
Avg Vol (30d)0
Avg Vol (10d)5.80K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—